Pomelo Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$45.2M Hold
1,760,000
4.33% 6
2018
Q2
$40.9M Sell
1,760,000
-101,900
-5% -$2.11M 4% 5
2018
Q1
$29.5M Sell
1,861,900
-324,100
-15% -$6.03M 1.61% 27
2017
Q4
$31.3M Buy
2,186,000
+1,138,900
+109% +$18.1M 0.93% 37
2017
Q3
$15M Buy
1,047,100
+384,000
+58% +$5.81M 0.5% 59
2017
Q2
$11.5M Hold
663,100
0.5% 48
2017
Q1
$7.31M Sell
663,100
-549,300
-45% -$7.56M 0.37% 58
2016
Q4
$31.9M Sell
1,212,400
-566,500
-32% -$10.4M 1.43% 16
2016
Q3
$46.8M Buy
1,778,900
+64,000
+4% +$1.66M 2.15% 11
2016
Q2
$45.1M Buy
1,714,900
+518,100
+43% +$14.7M 2.29% 10
2016
Q1
$31.5M Buy
1,196,800
+688,300
+135% +$50.9M 1.81% 13
2015
Q4
$3.49M Buy
508,500
+483,500
+1,934% +$54.3M 1.25% 25
2015
Q3
$509K Buy
+25,000
New +$5.83M 0.21% 67

Other funds holding BHC

Pomelo Capital's BHC Position: Q3 2018 in Review

Pomelo Capital held its Bausch Health (BHC) position steady in Q3 2018 at 60,000 shares worth $1.54M. The position accounts for 0.15% of the portfolio, ranked #51.

Pomelo Capital first reported a position in BHC in Q1 2016 and has held it in 8 quarters since. The position peaked at $17.8M in Q3 2016. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

  • Pomelo Capital held 60,000 shares of Bausch Health worth $1.54M as of Q3 2018.
  • Pomelo Capital left its Bausch Health share count unchanged in Q3 2018.
  • Bausch Health made up 0.15% of Pomelo Capital's portfolio in Q3 2018, its #51 holding.
  • Pomelo Capital first reported a position in Bausch Health in Q1 2016 and has held it in 8 quarters since.
  • Pomelo Capital's Bausch Health position peaked at $17.8M in Q3 2016.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Pomelo Capital's 13F filing for Q3 2018, filed 14 Nov 2018.